Kala Pharmaceuticals Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Kala Pharmaceuticals Inc
CIK #0001479419
EDGAR Form CIK 2011 - 2026
10-K [0001479419]
10-Q [0001479419]
3 [0001479419]
4 [0001479419]
8-K [0001479419]
D [0001479419]
SC 13D [0001479419]
SC 13G [0001479419]
Form 13D/13G Filer Form 13D/13G Subject Filed
Lazar David E Kala Bio Inc [2026-02-06]
Lifesci Capital LLC Kala Bio Inc [2026-01-13]
Oxford Finance LLC Kala Bio Inc [2025-12-03]
Baker Bros Advisors LP Kala Bio Inc [2025-10-03]
Cormorant Asset Management LP Kala Bio Inc [2025-02-14]
ADAR1 Capital Management LLC Kala Bio Inc [2024-11-14]
SR One Capital Management LLC Kala Bio Inc [2024-07-08]
Baker Bros Advisors LP Kala Bio Inc [2024-06-28]
Millennium Management LLC Kala Bio Inc [2024-02-16]
Checkpoint Capital LP Kala Pharmaceuticals Inc [2023-06-15]
View All
Form 3/4/5 Subject 2011 - 2026
Purdy Brendan P
Kala Bio Inc
Colman Yonatan C
Berger Chaim D
Posen Hillel D
Minkowitz Avraham
Lazar David E
Oxford Finance LLC
Iwicki Mark T
Reumuth Mary
Bazemore Todd
Brazzell Romulus K
Kharabi Darius
Baker Bros Advisors GP LLC
Baker Julian
Baker Felix
Baker Bros Advisors LP
Rosen Howard B
Farid Marjan
Perry Gregory D
Myers C Daniel
Koven Andrew I
Blumenkranz Mark S
Trachtenberg Eric
Paull Robert Bradley
Shah Rajeev M
RA Capital Healthcare Fund LP
RA Capital Management LP
Kolchinsky Peter
Chen Hongming
Grunberg Gregory
Langer Robert
Hill Paulina
OrbiMed Capital GP VI LLC
OrbiMed Advisors LLC
LaRussa Michele
Isaly Samuel D
Longitude Venture Partners II LP
Longitude Capital Partners II LLC
Enright Patrick G
Tammenoms Bakker Juliet
Tepper Robert I
Hadley Harbor Master Investors Cayman LP
Kovner Bruce
CDK Associates LLC
Caxton Corp
Hanes Justin
McDermott Charles Douglas
Lux Capital Management LLC
Lux Venture Partners II LP
Lux Venture Associates II LLC
Lux Ventures II Sidecar LP
Lux Ventures II LP
Polaris Venture Partners V LP
Polaris Venture Partners Entrepreneurs' Fund V LP
Polaris Venture Management Co V LLC
Polaris Venture Partners Founders' Fund V LP
Polaris Venture Partners Special Founders' Fund V LP
Ysios BioFund I FCR
CVF LLC
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Kala Bio Inc KALA
Convertible Loan · derivative
2025-12-18 Other 368,614
Kala Bio Inc KALA
Series AA Convertible Preferred Stock · derivative
2025-11-24 Grant 900,000
Kala Bio Inc KALA
Common Stock
2025-10-23 Sell 967 $0.82 793
Kala Bio Inc KALA
Common Stock
2025-10-23 Sell 154,894 $0.81 125,464
Kala Bio Inc KALA
Common Stock
2025-10-22 Sell 47,768 $0.83 39,647
Kala Bio Inc KALA
Common Stock
2025-10-22 Sell 20,806 $0.83 17,269
Kala Bio Inc KALA
Common Stock
2025-10-22 Sell 46,748 $0.83 38,801
Kala Bio Inc KALA
Common Stock
2025-10-22 Sell 32,230 $0.83 26,751
Kala Bio Inc KALA
Common Stock
2025-10-01 Sell 462,967 $1.38 638,894
Kala Bio Inc KALA
Common Stock
2025-10-01 Sell 50,640 $1.38 69,883
Kala Bio Inc KALA
Common Stock
2025-09-30 Sell 21,376 $1.60 34,202
Kala Bio Inc KALA
Common Stock
2025-09-30 Sell 195,425 $1.60 312,680
Kala Bio Inc KALA
Common Stock
2025-06-24 Sell 13,227 $4.01 53,040
Kala Bio Inc KALA
Common Stock
2025-06-24 Sell 4,511 $4.01 18,089
Kala Bio Inc KALA
Common Stock
2025-06-24 Sell 3,631 $4.01 14,560
Kala Bio Inc KALA
Common Stock
2025-06-24 Sell 5,251 $4.01 21,057
Kala Bio Inc KALA
Common Stock
2025-06-24 Sell 4,058 $4.01 16,273
Kala Bio Inc KALA
Common Stock
2025-06-15 Grant 2,450 $0.00
Kala Bio Inc KALA
Common Stock
2025-06-15 Grant 2,450 $0.00
Kala Bio Inc KALA
Stock Option (right to buy) · derivative
2025-06-15 Grant 5,450 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com